BMND15
MCID: BNM029
MIFTS: 48

Bone Mineral Density Quantitative Trait Locus 15 (BMND15)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Bone Mineral Density Quantitative Trait Locus 15

MalaCards integrated aliases for Bone Mineral Density Quantitative Trait Locus 15:

Name: Bone Mineral Density Quantitative Trait Locus 15 56 6 39
Osteoporosis 56 71
Metaphyseal Fracture, Susceptibility to 56
Compression Fracture, Susceptibility to 56
Osteoporosis, Susceptibility to 56
Fractures, Compression 71
Metaphyseal Fracture 56
Compression Fracture 56
Bmnd15 56

Characteristics:

OMIM:

56
Inheritance:
autosomal recessive
autosomal dominant


HPO:

31
bone mineral density quantitative trait locus 15:
Inheritance autosomal dominant inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 56 613418
MedGen 41 C3150680
SNOMED-CT via HPO 68 258211005 263681008 64859006
UMLS 71 C0029456 C0521169

Summaries for Bone Mineral Density Quantitative Trait Locus 15

MalaCards based summary : Bone Mineral Density Quantitative Trait Locus 15, also known as osteoporosis, is related to osteoporosis and osteoporosis, juvenile, and has symptoms including tremor, angina pectoris and back pain. An important gene associated with Bone Mineral Density Quantitative Trait Locus 15 is MIR2861 (MicroRNA 2861). The drugs Linagliptin and Dinoprostone have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and prostate, and related phenotype is osteoporosis.

More information from OMIM: 613418

Related Diseases for Bone Mineral Density Quantitative Trait Locus 15

Diseases in the Bone Mineral Density Quantitative Trait Locus 15 family:

Bone Mineral Density Quantitative Trait Locus 4 Bone Mineral Density Quantitative Trait Locus 18
Bone Mineral Density Quantitative Trait Locus 1 Bone Mineral Density Quantitative Trait Locus 2
Bone Mineral Density Quantitative Trait Locus 3 Bone Mineral Density Quantitative Trait Locus 5
Bone Mineral Density Quantitative Trait Locus 6 Bone Mineral Density Quantitative Trait Locus 7
Bone Mineral Density Quantitative Trait Locus 8 Bone Mineral Density Quantitative Trait Locus 9
Bone Mineral Density Quantitative Trait Locus 10 Bone Mineral Density Quantitative Trait Locus 11
Bone Mineral Density Quantitative Trait Locus 12 Bone Mineral Density Quantitative Trait Locus 13
Bone Mineral Density Quantitative Trait Locus 14 Bone Mineral Density Quantitative Trait Locus 16
Bone Mineral Density Quantitative Trait Locus 17

Diseases related to Bone Mineral Density Quantitative Trait Locus 15 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1080, show less)
# Related Disease Score Top Affiliating Genes
1 osteoporosis 33.1 PDLIM4 MIR2861 CALCR
2 osteoporosis, juvenile 12.9
3 osteoporosis-pseudoglioma syndrome 12.8
4 nephrolithiasis/osteoporosis, hypophosphatemic, 1 12.6
5 glucocorticoid-induced osteoporosis 12.6
6 juvenile primary osteoporosis 12.6
7 nephrolithiasis/osteoporosis, hypophosphatemic, 2 12.5
8 osteoporosis and oculocutaneous hypopigmentation syndrome 12.5
9 macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 12.3
10 growth failure, microcephaly, mental retardation, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 12.2
11 dominant hypophosphatemia with nephrolithiasis or osteoporosis 12.2
12 hajdu-cheney syndrome 12.2
13 bone mineral density quantitative trait locus 8 12.2
14 amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 12.2
15 cutis laxa osteoporosis 12.1
16 osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 12.1
17 lrp5-related primary osteoporosis 12.1
18 bone mineral density quantitative trait locus 18 12.0
19 bone mineral density quantitative trait locus 16 11.8
20 premature ovarian failure 1 11.7
21 werner syndrome 11.6
22 aromatase deficiency 11.6
23 bone mineral density quantitative trait locus 12 11.6
24 bone disease 11.6
25 syndromic x-linked intellectual disability snyder type 11.6
26 lysinuric protein intolerance 11.5
27 mental retardation, x-linked, syndromic, snyder-robinson type 11.5
28 geroderma osteodysplasticum 11.5
29 hyperparathyroidism 11.5
30 rickets 11.5
31 premature aging syndrome, okamoto type 11.5
32 cerebrotendinous xanthomatosis 11.4
33 acth-secreting pituitary adenoma 11.4
34 cholangitis, primary sclerosing 11.4
35 spondyloocular syndrome 11.4
36 cleidocranial dysplasia 11.4
37 anorexia nervosa 11.4
38 celiac disease 1 11.4
39 systemic mastocytosis 11.4
40 spondyloepimetaphyseal dysplasia, shohat type 11.3
41 eating disorder 11.3
42 osteopetrosis 11.3
43 hypogonadotropic hypogonadism 11.3
44 multicentric osteolysis, nodulosis, and arthropathy 11.3
45 graves' disease 11.3
46 turner syndrome 11.3
47 severe congenital neutropenia 11.3
48 pituitary adenoma 4, acth-secreting 11.3
49 homocystinuria 11.3
50 calvarial doughnut lesions with bone fragility 11.3
51 exudative vitreoretinopathy 11.3
52 spinal disease 11.3
53 cleft palate, isolated 11.3
54 menkes disease 11.3
55 parathyroid carcinoma 11.3
56 dyskeratosis congenita 11.3
57 kallmann syndrome 11.3
58 47, xxy 11.3
59 winchester syndrome 11.3
60 bone resorption disease 11.2
61 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 11.2
62 mucolipidosis iii alpha/beta 11.2
63 nestor-guillermo progeria syndrome 11.2
64 hyperparathyroidism 1 11.1
65 dyskeratosis congenita, autosomal recessive 1 11.1
66 hyaline fibromatosis syndrome 11.1
67 mucolipidosis iii gamma 11.1
68 prader-willi habitus, osteopenia, and camptodactyly 11.1
69 osteogenesis imperfecta, type xii 11.1
70 dyskeratosis congenita, autosomal dominant 2 11.1
71 osteogenesis imperfecta, type xiii 11.1
72 dyskeratosis congenita, autosomal recessive 5 11.1
73 pigmented nodular adrenocortical disease, primary, 4 11.1
74 dyskeratosis congenita, autosomal dominant 6 11.1
75 ehlers-danlos syndrome, classic-like, 2 11.1
76 dyskeratosis congenita, autosomal dominant 1 11.0
77 hyperparathyroidism 2 with jaw tumors 11.0
78 singleton-merten syndrome 1 11.0
79 aspartylglucosaminuria 11.0
80 cardiomyopathy, dilated, with hypergonadotropic hypogonadism 11.0
81 acth-independent macronodular adrenal hyperplasia 11.0
82 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 11.0
83 achalasia-addisonianism-alacrima syndrome 11.0
84 glycogen storage disease ia 11.0
85 growth hormone insensitivity with immunodeficiency 11.0
86 diarrhea 2, with microvillus atrophy 11.0
87 bruck syndrome 1 11.0
88 parana hard-skin syndrome 11.0
89 rothmund-thomson syndrome, type 2 11.0
90 spondyloepimetaphyseal dysplasia, sponastrime type 11.0
91 dyskeratosis congenita, x-linked 11.0
92 kallmann syndrome with spastic paraplegia 11.0
93 stuve-wiedemann syndrome 11.0
94 pigmented nodular adrenocortical disease, primary, 2 11.0
95 pigmented nodular adrenocortical disease, primary, 1 11.0
96 osteogenesis imperfecta, type viii 11.0
97 candidiasis, familial, 6 11.0
98 dyskeratosis congenita, autosomal recessive 2 11.0
99 dyskeratosis congenita, autosomal recessive 3 11.0
100 dyskeratosis congenita, autosomal dominant 3 11.0
101 pigmented nodular adrenocortical disease, primary, 3 11.0
102 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 11.0
103 estrogen resistance 11.0
104 acth-independent macronodular adrenal hyperplasia 2 11.0
105 analbuminemia 11.0
106 dyskeratosis congenita, autosomal recessive 6 11.0
107 thrombocytopenia 6 11.0
108 ovarian dysgenesis 8 11.0
109 primary pigmented nodular adrenocortical disease 11.0
110 46 xy gonadal dysgenesis 11.0
111 atypical werner syndrome 11.0
112 neonatal adrenoleukodystrophy 11.0
113 singleton-merten syndrome 11.0
114 idiopathic infantile hypercalcemia 11.0
115 bone mineral density quantitative trait locus 3 10.9
116 osteoarthritis 10.8
117 osteonecrosis 10.8
118 hypogonadism 10.8
119 hypogonadotropism 10.8
120 osteomalacia 10.8
121 back pain 10.7
122 osteonecrosis of the jaw 10.7
123 rheumatoid arthritis 10.7
124 secondary hyperparathyroidism 10.6
125 mammary paget's disease 10.6
126 arthritis 10.6
127 triiodothyronine receptor auxiliary protein 10.6
128 brittle bone disorder 10.6
129 primary hyperparathyroidism 10.6
130 hyperthyroidism 10.6
131 inflammatory bowel disease 10.6
132 periodontitis 10.5
133 amenorrhea 10.5
134 diabetes mellitus 10.5
135 body mass index quantitative trait locus 1 10.5
136 pulmonary disease, chronic obstructive 10.5
137 chronic kidney disease 10.5
138 inflammatory spondylopathy 10.5
139 spondylitis 10.5
140 spondyloarthropathy 1 10.5
141 thalassemia 10.5
142 spinal cord injury 10.5
143 insulin-like growth factor i 10.4
144 liver disease 10.4
145 mastocytosis 10.4
146 liver cirrhosis 10.4
147 alcohol use disorder 10.4
148 aging 10.4
149 arterial calcification, generalized, of infancy, 1 10.4
150 kidney disease 10.4
151 prostate cancer 10.4
152 sclerosteosis 10.4
153 avascular necrosis 10.4
154 endometrial cancer 10.4
155 primary biliary cirrhosis 10.4
156 chronic pain 10.4
157 alcohol dependence 10.4
158 autoimmune disease 10.4
159 myeloma, multiple 10.4
160 rheumatic disease 10.4
161 crohn's disease 10.4
162 atherosclerosis susceptibility 10.3
163 breast cancer 10.3
164 hypothyroidism 10.3
165 lipid metabolism disorder 10.3
166 scoliosis 10.3
167 arthropathy 10.3
168 nephrolithiasis, calcium oxalate 10.3
169 osteogenic sarcoma 10.3
170 paget's disease of bone 10.3
171 lung disease 10.3
172 cystic fibrosis 10.3
173 body mass index quantitative trait locus 11 10.3
174 body mass index quantitative trait locus 9 10.3
175 body mass index quantitative trait locus 8 10.3
176 body mass index quantitative trait locus 4 10.3
177 body mass index quantitative trait locus 10 10.3
178 body mass index quantitative trait locus 7 10.3
179 body mass index quantitative trait locus 12 10.3
180 body mass index quantitative trait locus 14 10.3
181 body mass index quantitative trait locus 18 10.3
182 body mass index quantitative trait locus 19 10.3
183 body mass index quantitative trait locus 20 10.3
184 systemic lupus erythematosus 10.3
185 graves disease 1 10.3
186 beta-thalassemia 10.3
187 renal osteodystrophy 10.3
188 47,xyy 10.3
189 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
190 hemosiderosis 10.3
191 rare hereditary hemochromatosis 10.3
192 fibrosis of extraocular muscles, congenital, 1 10.3
193 lupus erythematosus 10.3
194 yemenite deaf-blind hypopigmentation syndrome 10.2
195 coronary heart disease 1 10.2
196 hydrops, lactic acidosis, and sideroblastic anemia 10.2
197 synovitis 10.2
198 hyperglycemia 10.2
199 endometrial hyperplasia 10.2
200 vascular disease 10.2
201 paraplegia 10.2
202 connective tissue disease 10.2
203 endosteal hyperostosis, autosomal dominant 10.2
204 temporal arteritis 10.2
205 autosomal recessive disease 10.2
206 premature menopause 10.2
207 muscular dystrophy 10.2
208 rapidly involuting congenital hemangioma 10.2
209 lactose intolerance 10.2
210 heart disease 10.2
211 cholestasis 10.2
212 cerebral palsy 10.2
213 acromegaly 10.2
214 cerebrovascular disease 10.2
215 peptic ulcer disease 10.2
216 depression 10.2
217 hyperprolactinemia 10.2
218 lymphocytic leukemia 10.2
219 urticaria 10.2
220 enthesopathy 10.2
221 ulcerative colitis 10.2
222 acroosteolysis 10.2
223 hypercholesterolemia, familial, 1 10.2
224 spondylolisthesis 10.2
225 hypogonadism, male 10.2
226 osteomyelitis 10.2
227 hypoparathyroidism 10.2
228 vitamin k deficiency bleeding 10.2
229 esophagitis 10.2
230 algoneurodystrophy 10.2
231 muscular atrophy 10.2
232 gastrointestinal system disease 10.2
233 reflex sympathetic dystrophy 10.1
234 leukemia, acute lymphoblastic 10.1
235 hyperostosis 10.1
236 gastritis 10.1
237 juvenile rheumatoid arthritis 10.1
238 48,xyyy 10.1
239 pik3ca-related overgrowth syndrome 10.1
240 multiple sclerosis 10.1
241 dermatomyositis 10.1
242 spondylosis 10.1
243 dermatitis 10.1
244 bone inflammation disease 10.1
245 cataract 10.1
246 pemphigus 10.1
247 growth hormone deficiency 10.1
248 idiopathic hypercalciuria 10.1
249 thyroid carcinoma 10.1
250 muscular dystrophy, duchenne type 10.1
251 psoriatic arthritis 10.1
252 benign paroxysmal positional nystagmus 10.1
253 constipation 10.1
254 arteriosclerosis 10.1
255 congestive heart failure 10.1
256 rare disease in surgical orthopedic 10.1
257 gastroesophageal reflux 10.1
258 mastocytosis, cutaneous 10.1
259 scleroderma, familial progressive 10.1
260 homocysteinemia 10.1
261 deficiency anemia 10.1
262 hyperphosphatemia 10.1
263 hemiplegia 10.1
264 conn's syndrome 10.1
265 myopathy 10.1
266 degenerative disc disease 10.1
267 alzheimer disease 10.1
268 schizophrenia 10.1
269 periodontitis, chronic 10.1
270 neutropenia 10.1
271 uveitis 10.1
272 gout 10.1
273 impotence 10.1
274 ankylosis 10.1
275 pustulosis of palm and sole 10.1
276 adenoma 10.1
277 psoriasis 10.1
278 hypopituitarism 10.1
279 dysphagia 10.1
280 esophageal cancer 10.1
281 sarcoidosis 1 10.1
282 hemochromatosis, type 1 10.1
283 asthma 10.1
284 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
285 peripheral vascular disease 10.1
286 hypophosphatemia 10.1
287 gingival recession 10.1
288 leukemia 10.1
289 nephrocalcinosis 10.1
290 diarrhea 10.1
291 renal tubular acidosis 10.1
292 hyperinsulinism 10.1
293 iron metabolism disease 10.1
294 complex regional pain syndrome 10.1
295 cellulitis 10.1
296 skin disease 10.1
297 end stage renal failure 10.1
298 fatty liver disease 10.1
299 cytokine deficiency 10.1
300 arteries, anomalies of 10.0
301 colorectal cancer 10.0
302 helicobacter pylori infection 10.0
303 stroke, ischemic 10.0
304 pitt-hopkins syndrome 10.0
305 metabolic acidosis 10.0
306 fibrous dysplasia 10.0
307 non-alcoholic fatty liver disease 10.0
308 dementia 10.0
309 hyperuricemia 10.0
310 dental caries 10.0
311 bronchitis 10.0
312 vasculitis 10.0
313 neurofibromatosis, type iv, of riccardi 10.0
314 hypoascorbemia 10.0
315 creatinine clearance quantitative trait locus 10.0
316 gastric cancer 10.0
317 leukemia, acute lymphoblastic 3 10.0
318 exanthem 10.0
319 sleep apnea 10.0
320 colitis 10.0
321 childhood acute lymphocytic leukemia 10.0
322 respiratory failure 10.0
323 nephrotic syndrome 10.0
324 gonadal dysgenesis 10.0
325 exostosis 10.0
326 idiopathic interstitial pneumonia 10.0
327 osteitis fibrosa 10.0
328 pulmonary fibrosis 10.0
329 rhinitis 10.0
330 indolent systemic mastocytosis 10.0
331 spinal stenosis 10.0
332 collagen disease 10.0
333 cholangitis 10.0
334 bronchiectasis 10.0
335 hemophilia 10.0
336 premature aging 10.0
337 pemphigus vulgaris, familial 10.0
338 down syndrome 10.0
339 van buchem disease 10.0
340 myasthenia gravis 10.0
341 hyperlipoproteinemia, type iii 10.0
342 atrial fibrillation 10.0
343 idiopathic scoliosis 10.0
344 siderosis 10.0
345 coronary artery anomaly 10.0
346 allergic hypersensitivity disease 10.0
347 goiter 10.0
348 ehlers-danlos syndrome 10.0
349 calcinosis 10.0
350 hepatitis c 10.0
351 endometriosis 10.0
352 systemic scleroderma 10.0
353 poliomyelitis 10.0
354 fibromyalgia 10.0
355 monoclonal gammopathy of uncertain significance 10.0
356 septic arthritis 10.0
357 cardiac arrest 10.0
358 acute cystitis 10.0
359 alkuraya-kucinskas syndrome 9.9
360 clubfoot 9.9
361 congenital amyoplasia 9.9
362 diabetes mellitus, noninsulin-dependent 9.9
363 retinal detachment 9.9
364 leprosy 3 9.9
365 proteasome-associated autoinflammatory syndrome 1 9.9
366 pycnodysostosis 9.9
367 bulimia nervosa 9.9
368 myocardial infarction 9.9
369 hepatitis c virus 9.9
370 alacrima, achalasia, and mental retardation syndrome 9.9
371 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
372 sexual disorder 9.9
373 estrogen-receptor positive breast cancer 9.9
374 spondyloarthropathy 9.9
375 polycystic ovary syndrome 9.9
376 iron deficiency anemia 9.9
377 thrombocytopenia 9.9
378 epilepsy 9.9
379 epidermolysis bullosa 9.9
380 plasmacytoma 9.9
381 thyroid gland disease 9.9
382 intestinal disease 9.9
383 parathyroid adenoma 9.9
384 neuropathy 9.9
385 pulmonary embolism 9.9
386 alopecia 9.9
387 hypoglycemia 9.9
388 hansen's disease 9.9
389 polymyositis 9.9
390 differentiated thyroid carcinoma 9.9
391 rare surgical neurologic disease 9.9
392 hepatocellular carcinoma 9.9
393 hypertriglyceridemia, familial 9.9
394 myositis 9.9
395 osteogenesis imperfecta, type i 9.9
396 pernicious anemia 9.9
397 scheuermann disease 9.9
398 trichorhinophalangeal syndrome, type i 9.9
399 lipoid congenital adrenal hyperplasia 9.9
400 hypophosphatemic rickets, x-linked recessive 9.9
401 ataxia and polyneuropathy, adult-onset 9.9
402 pituitary adenoma, prolactin-secreting 9.9
403 xanthomatosis 9.9
404 dermatitis, atopic 9.9
405 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
406 microvascular complications of diabetes 3 9.9
407 microvascular complications of diabetes 4 9.9
408 microvascular complications of diabetes 6 9.9
409 microvascular complications of diabetes 7 9.9
410 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.9
411 peripheral artery disease 9.9
412 lymphoma 9.9
413 crohn's colitis 9.9
414 infant gynecomastia 9.9
415 otosclerosis 9.9
416 gynecomastia 9.9
417 peptic esophagitis 9.9
418 childhood type dermatomyositis 9.9
419 mental depression 9.9
420 substance abuse 9.9
421 acute kidney failure 9.9
422 gingivitis 9.9
423 skin carcinoma 9.9
424 radiculopathy 9.9
425 neuromuscular disease 9.9
426 hypokalemia 9.9
427 epidermolysis bullosa dystrophica 9.9
428 pancreatitis 9.9
429 infertility 9.9
430 sleep disorder 9.9
431 peripheral nervous system disease 9.9
432 lymphopenia 9.9
433 herpes zoster 9.9
434 pulmonary emphysema 9.9
435 irritable bowel syndrome 9.9
436 hemophilic arthropathy 9.9
437 splenomegaly 9.9
438 brain injury 9.9
439 hypotonia 9.9
440 hypoxia 9.9
441 spasticity 9.9
442 systemic autoimmune disease 9.9
443 overgrowth syndrome 9.9
444 cauda equina syndrome 9.9
445 leiomyosarcoma 9.9
446 intestinal obstruction 9.9
447 ileus 9.9
448 al amyloidosis 9.9
449 migraine with or without aura 1 9.8
450 neurofibromatosis, type i 9.8
451 mccune-albright syndrome 9.8
452 hutchinson-gilford progeria syndrome 9.8
453 neural tube defects 9.8
454 spondylosis, cervical 9.8
455 thrombophilia due to thrombin defect 9.8
456 persistent hyperplastic primary vitreous, autosomal recessive 9.8
457 immune deficiency disease 9.8
458 mend syndrome 9.8
459 arts syndrome 9.8
460 rett syndrome 9.8
461 allergic rhinitis 9.8
462 major depressive disorder 9.8
463 major affective disorder 8 9.8
464 major affective disorder 9 9.8
465 premature ovarian failure 7 9.8
466 non-alcoholic steatohepatitis 9.8
467 sensorineural hearing loss 9.8
468 nasopharyngitis 9.8
469 gastric ulcer 9.8
470 prostatic hypertrophy 9.8
471 quadriplegia 9.8
472 cardiovascular system disease 9.8
473 exocrine pancreatic insufficiency 9.8
474 sclerosing cholangitis 9.8
475 primary hypertrophic osteoarthropathy 9.8
476 candidiasis 9.8
477 viral hepatitis 9.8
478 hepatitis b 9.8
479 autoimmune hepatitis 9.8
480 psychotic disorder 9.8
481 hemoglobinopathy 9.8
482 prostatic adenoma 9.8
483 acute pancreatitis 9.8
484 adenocarcinoma 9.8
485 testicular cancer 9.8
486 interstitial lung disease 9.8
487 bipolar disorder 9.8
488 mood disorder 9.8
489 purpura 9.8
490 pituitary adenoma 9.8
491 milk allergy 9.8
492 adrenal adenoma 9.8
493 bullous pemphigoid 9.8
494 atrophic gastritis 9.8
495 amyloidosis 9.8
496 meningitis 9.8
497 hypervitaminosis d 9.8
498 col1a1/2 osteogenesis imperfecta 9.8
499 trichorhinophalangeal syndrome 9.8
500 aminoaciduria 9.8
501 distal renal tubular acidosis 9.8
502 oncogenic osteomalacia 9.8
503 age-related hearing loss 9.8
504 autonomic dysfunction 9.8
505 syncope 9.8
506 traumatic brain injury 9.8
507 inflammatory myopathy with abundant macrophages 9.8
508 vitreoretinopathy 9.8
509 amyotrophic lateral sclerosis 1 9.7
510 bladder cancer 9.7
511 corneal dystrophy, epithelial basement membrane 9.7
512 multiple endocrine neoplasia, type i 9.7
513 exostoses, multiple, type i 9.7
514 hand skill, relative 9.7
515 hernia, hiatus 9.7
516 hypercalciuria, absorptive, 2 9.7
517 hypercalcemia, infantile, 1 9.7
518 renal cell carcinoma, nonpapillary 9.7
519 hyperostosis frontalis interna 9.7
520 hypertension, essential 9.7
521 inclusion body myositis 9.7
522 marfan syndrome 9.7
523 ovarian cancer 9.7
524 polykaryocytosis inducer 9.7
525 prader-willi syndrome 9.7
526 pulmonary fibrosis, idiopathic 9.7
527 scoliosis, isolated 1 9.7
528 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.7
529 diabetes mellitus, insulin-dependent 9.7
530 gaucher disease, type i 9.7
531 hypervitaminosis a 9.7
532 familial mediterranean fever 9.7
533 shwachman-diamond syndrome 1 9.7
534 pituitary hormone deficiency, combined, 2 9.7
535 sjogren syndrome 9.7
536 hypothyroidism, congenital, nongoitrous, 4 9.7
537 fabry disease 9.7
538 taqi polymorphism 9.7
539 prostatic hyperplasia, benign 9.7
540 sickle cell anemia 9.7
541 langerhans cell histiocytosis 9.7
542 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.7
543 huntington disease-like 2 9.7
544 anxiety 9.7
545 prostate cancer, hereditary, 4 9.7
546 intraocular pressure quantitative trait locus 9.7
547 lung cancer susceptibility 3 9.7
548 microvascular complications of diabetes 5 9.7
549 fatty liver disease, nonalcoholic 1 9.7
550 graft-versus-host disease 9.7
551 bone mineral density quantitative trait locus 17 9.7
552 pulmonary hypertension 9.7
553 chlamydia pneumonia 9.7
554 brachydactyly 9.7
555 female breast cancer 9.7
556 vitamin b12 deficiency 9.7
557 progesterone-receptor positive breast cancer 9.7
558 pain agnosia 9.7
559 myelomeningocele 9.7
560 recessive dystrophic epidermolysis bullosa 9.7
561 stickler syndrome 9.7
562 silicosis 9.7
563 pre-eclampsia 9.7
564 glucose intolerance 9.7
565 short bowel syndrome 9.7
566 fanconi syndrome 9.7
567 microphthalmia 9.7
568 renal hypertension 9.7
569 portal hypertension 9.7
570 hydrocephalus 9.7
571 cholesteatoma of middle ear 9.7
572 ovarian disease 9.7
573 hydronephrosis 9.7
574 sarcoma 9.7
575 chlamydia 9.7
576 blind hypotensive eye 9.7
577 visual epilepsy 9.7
578 low compliance bladder 9.7
579 secondary hyperparathyroidism of renal origin 9.7
580 acute leukemia 9.7
581 guillain-barre syndrome 9.7
582 dental fluorosis 9.7
583 hypophosphatasia 9.7
584 adult-onset still's disease 9.7
585 46 xx gonadal dysgenesis 9.7
586 gingival disease 9.7
587 angioedema 9.7
588 ectropion 9.7
589 endogenous depression 9.7
590 lymphadenitis 9.7
591 pneumothorax 9.7
592 cystitis 9.7
593 ichthyosis 9.7
594 duodenal ulcer 9.7
595 neuritis 9.7
596 bone cancer 9.7
597 gaucher's disease 9.7
598 vaginitis 9.7
599 lateral sclerosis 9.7
600 hemangioma 9.7
601 glomerulonephritis 9.7
602 antiphospholipid syndrome 9.7
603 lipomatosis 9.7
604 inappropriate adh syndrome 9.7
605 histiocytosis 9.7
606 mixed connective tissue disease 9.7
607 empty sella syndrome 9.7
608 gastric adenocarcinoma 9.7
609 anovulation 9.7
610 craniopharyngioma 9.7
611 thrombophlebitis 9.7
612 pseudohypoparathyroidism 9.7
613 glucose metabolism disease 9.7
614 spindle cell sarcoma 9.7
615 atrophic rhinitis 9.7
616 human immunodeficiency virus infectious disease 9.7
617 severe combined immunodeficiency 9.7
618 acquired immunodeficiency syndrome 9.7
619 diffuse idiopathic skeletal hyperostosis 9.7
620 b-cell lymphoma 9.7
621 osteochondrosis 9.7
622 duodenitis 9.7
623 subacute delirium 9.7
624 myeloid leukemia 9.7
625 intermediate coronary syndrome 9.7
626 hard palate cancer 9.7
627 achalasia 9.7
628 postpartum depression 9.7
629 diabetic neuropathy 9.7
630 dystrophinopathies 9.7
631 satb2-associated syndrome 9.7
632 sickle cell disease 9.7
633 chronic graft versus host disease 9.7
634 glioma 9.7
635 secondary adrenal insufficiency 9.7
636 skeletal dysplasias 9.7
637 spondylarthropathy 9.7
638 stevens-johnson syndrome/toxic epidermal necrolysis 9.7
639 tuberculous meningitis 9.7
640 multiple endocrine neoplasia 9.7
641 pituitary tumors 9.7
642 postherpetic neuralgia 9.7
643 seizure disorder 9.7
644 glial tumor 9.7
645 progeroid syndrome 9.7
646 glomerular disease 9.7
647 undetermined colitis 9.7
648 cystic angiomatosis of bone, diffuse 9.7
649 lipomatosis, multiple 9.7
650 thyroid cancer, nonmedullary, 2 9.7
651 chondrosarcoma 9.7
652 polycythemia vera 9.7
653 retinoschisis 1, x-linked, juvenile 9.7
654 ventricular fibrillation, paroxysmal familial, 1 9.7
655 cyanosis, transient neonatal 9.7
656 aspiration pneumonia 9.7
657 mantle cell lymphoma 9.7
658 aphasia 9.7
659 pleomorphic lipoma 9.7
660 amnestic disorder 9.7
661 pulmonary edema 9.7
662 atrial heart septal defect 9.7
663 spondylolysis 9.7
664 tic disorder 9.7
665 neurilemmoma 9.7
666 temporal lobe epilepsy 9.7
667 intermittent claudication 9.7
668 pleural empyema 9.7
669 thyroid gland follicular carcinoma 9.7
670 erdheim-chester disease 9.7
671 intracranial embolism 9.7
672 brain edema 9.7
673 polycythemia 9.7
674 fibrous dysplasia/mccune-albright syndrome 9.7
675 bone marrow necrosis 9.7
676 dieterich's disease 9.7
677 lymphangiomatosis 9.7
678 rosai-dorfman disease 9.7
679 cerebral atrophy 9.7
680 head injury 9.7
681 b-cell non-hodgkin lymphoma 9.7
682 isoniazid toxicity 9.7
683 neurofibromatosis, type ii 9.6
684 pseudohypoparathyroidism, type ia 9.6
685 angelman syndrome 9.6
686 epidermolytic hyperkeratosis 9.6
687 burkitt lymphoma 9.6
688 arthrogryposis, distal, type 3 9.6
689 cardiac arrhythmia 9.6
690 carpal tunnel syndrome 9.6
691 leukocyte adhesion deficiency, type i 9.6
692 chiari malformation type i 9.6
693 coloboma of macula 9.6
694 ehlers-danlos syndrome, classic type, 1 9.6
695 exostoses, multiple, type ii 9.6
696 exudative vitreoretinopathy 1 9.6
697 factor viii deficiency 9.6
698 fibrodysplasia ossificans progressiva 9.6
699 hair whorl 9.6
700 hypogonadotropic hypogonadism 7 with or without anosmia 9.6
701 multiple system atrophy 1 9.6
702 ichthyosis vulgaris 9.6
703 hyper-ige recurrent infection syndrome 1, autosomal dominant 9.6
704 jacobsen syndrome 9.6
705 leukemia, chronic lymphocytic 9.6
706 lipomatosis, multiple symmetric 9.6
707 moebius syndrome 9.6
708 facioscapulohumeral muscular dystrophy 1 9.6
709 myelopathy, htlv-1-associated 9.6
710 oculopharyngeal muscular dystrophy 9.6
711 gnathodiaphyseal dysplasia 9.6
712 otitis media 9.6
713 papillomatosis, confluent and reticulated 9.6
714 parkinson disease, late-onset 9.6
715 pityriasis rubra pilaris 9.6
716 protoporphyria, erythropoietic, 1 9.6
717 protrusio acetabuli 9.6
718 pulmonary hypertension, primary, 1 9.6
719 dowling-degos disease 1 9.6
720 retinoblastoma 9.6
721 schistosoma mansoni infection, susceptibility/ 9.6
722 spondyloepimetaphyseal dysplasia, strudwick type 9.6
723 syringomyelia, noncommunicating isolated 9.6
724 thrombophilia due to activated protein c resistance 9.6
725 thyroid cancer, nonmedullary, 1 9.6
726 tobacco addiction 9.6
727 trigeminal neuralgia 9.6
728 tuberous sclerosis 1 9.6
729 urate oxidase, pseudogene 9.6
730 varicose veins 9.6
731 vitreoretinopathy, neovascular inflammatory 9.6
732 von hippel-lindau syndrome 9.6
733 neuropathy, hereditary sensory and autonomic, type iia 9.6
734 arachnoid cysts, intracranial 9.6
735 craniodiaphyseal dysplasia 9.6
736 neuropathy, hereditary sensory and autonomic, type iii 9.6
737 enterocolitis 9.6
738 galactorrhea 9.6
739 glycogen storage disease ii 9.6
740 renal glucosuria 9.6
741 ovarian dysgenesis 1 9.6
742 lymphoma, hodgkin, classic 9.6
743 hutterite cerebroosteonephrodysplasia syndrome 9.6
744 hydrocephalus, normal-pressure 9.6
745 mckusick-kaufman syndrome 9.6
746 chylomicron retention disease 9.6
747 muscular dystrophy, limb-girdle, autosomal recessive 2 9.6
748 myelofibrosis 9.6
749 ocular motor apraxia 9.6
750 gyrate atrophy of choroid and retina 9.6
751 osteogenesis imperfecta, type iii 9.6
752 osteoid osteoma 9.6
753 osteopetrosis, autosomal recessive 1 9.6
754 pancreatic cancer 9.6
755 laron syndrome 9.6
756 taurodontism 9.6
757 mayer-rokitansky-kuster-hauser syndrome 9.6
758 spondylocostal dysostosis 1, autosomal recessive 9.6
759 xeroderma pigmentosum, variant type 9.6
760 alopecia, congenital 9.6
761 coats disease 9.6
762 hemophilia a 9.6
763 hemophilia b 9.6
764 lowe oculocerebrorenal syndrome 9.6
765 norrie disease 9.6
766 kearns-sayre syndrome 9.6
767 oncocytoma 9.6
768 deafness, aminoglycoside-induced 9.6
769 gonadal agenesis 9.6
770 gallbladder disease 1 9.6
771 transsexuality 9.6
772 suppression of tumorigenicity 12 9.6
773 hypocalcemia, autosomal dominant 1 9.6
774 dental anomalies and short stature 9.6
775 dermatitis herpetiformis, familial 9.6
776 leukemia, acute myeloid 9.6
777 bone mineral density quantitative trait locus 1 9.6
778 hemochromatosis, type 2a 9.6
779 ossification of the posterior longitudinal ligament of spine 9.6
780 macular degeneration, age-related, 1 9.6
781 cervical cancer 9.6
782 chudley-mccullough syndrome 9.6
783 aceruloplasminemia 9.6
784 orthostatic intolerance 9.6
785 huntington disease-like 3 9.6
786 lymphoma, non-hodgkin, familial 9.6
787 paragangliomas 3 9.6
788 late-onset retinal degeneration 9.6
789 bone mineral density quantitative trait locus 2 9.6
790 genitopatellar syndrome 9.6
791 muscular dystrophy-dystroglycanopathy , type c, 5 9.6
792 epileptic encephalopathy, early infantile, 6 9.6
793 carotid intimal medial thickness 2 9.6
794 severe cutaneous adverse reaction 9.6
795 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 9.6
796 carney complex variant 9.6
797 aplastic anemia 9.6
798 mevalonic aciduria 9.6
799 asthma-related traits 4 9.6
800 osteogenesis imperfecta, type v 9.6
801 bone mineral density quantitative trait locus 7 9.6
802 glass syndrome 9.6
803 hypophosphatemic rickets, autosomal recessive, 2 9.6
804 alpha-1-antitrypsin deficiency 9.6
805 complement component 3 deficiency, autosomal recessive 9.6
806 microcephaly, epilepsy, and diabetes syndrome 9.6
807 myelodysplastic syndrome 9.6
808 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
809 leptin deficiency or dysfunction 9.6
810 leptin receptor deficiency 9.6
811 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.6
812 osteogenesis imperfecta, type xv 9.6
813 seizures, scoliosis, and macrocephaly/microcephaly syndrome 9.6
814 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.6
815 hyperparathyroidism 4 9.6
816 helix syndrome 9.6
817 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.6
818 angina pectoris 9.6
819 tendinitis 9.6
820 tendinosis 9.6
821 kashin-beck disease 9.6
822 erythema multiforme 9.6
823 loeys-dietz syndrome 9.6
824 variola major 9.6
825 congenital generalized lipodystrophy 9.6
826 arterial calcification of infancy 9.6
827 limb ischemia 9.6
828 colorectal adenoma 9.6
829 fibroma 9.6
830 autosomal recessive hypophosphatemic rickets 9.6
831 autism spectrum disorder 9.6
832 paraphilia disorder 9.6
833 alexithymia 9.6
834 microscopic colitis 9.6
835 ileitis 9.6
836 persistent hyperplastic primary vitreous 9.6
837 parietal foramina 9.6
838 pollen allergy 9.6
839 drug allergy 9.6
840 autosomal recessive congenital ichthyosis 9.6
841 muscular disease 9.6
842 acromesomelic dysplasia 9.6
843 superior semicircular canal dehiscence 9.6
844 nodal marginal zone lymphoma 9.6
845 hemochromatosis type 2 9.6
846 corneal disease 9.6
847 dry eye syndrome 9.6
848 cholelithiasis 9.6
849 tuberculoid leprosy 9.6
850 pneumoconiosis 9.6
851 anthracosis 9.6
852 yaws 9.6
853 bacterial infectious disease 9.6
854 protein-losing enteropathy 9.6
855 open-angle glaucoma 9.6
856 chronic pyelonephritis 9.6
857 chronic frontal sinusitis 9.6
858 frontal sinusitis 9.6
859 lepromatous leprosy 9.6
860 transsexualism 9.6
861 intracranial aneurysm 9.6
862 lipoid nephrosis 9.6
863 discitis 9.6
864 pulpitis 9.6
865 allergic conjunctivitis 9.6
866 erysipelas 9.6
867 tetanus 9.6
868 bladder calculus 9.6
869 pyelonephritis 9.6
870 diphtheria 9.6
871 horner's syndrome 9.6
872 autonomic neuropathy 9.6
873 chondrocalcinosis 9.6
874 hyperandrogenism 9.6
875 palindromic rheumatism 9.6
876 protein-energy malnutrition 9.6
877 postmenopausal atrophic vaginitis 9.6
878 neurogenic bladder 9.6
879 common variable immunodeficiency 9.6
880 oligohydramnios 9.6
881 cartilage disease 9.6
882 spinal muscular atrophy 9.6
883 tarsal tunnel syndrome 9.6
884 vestibular neuronitis 9.6
885 locked-in syndrome 9.6
886 leiomyoma 9.6
887 sialolithiasis 9.6
888 scleritis 9.6
889 tuberous sclerosis 9.6
890 eclampsia 9.6
891 patent foramen ovale 9.6
892 sick sinus syndrome 9.6
893 polyneuropathy 9.6
894 schistosomiasis 9.6
895 iritis 9.6
896 toxic shock syndrome 9.6
897 frozen shoulder 9.6
898 ochronosis 9.6
899 shoulder impingement syndrome 9.6
900 labyrinthitis 9.6
901 cholera 9.6
902 avoidant personality disorder 9.6
903 personality disorder 9.6
904 thrombocytopenia due to platelet alloimmunization 9.6
905 keratosis 9.6
906 ventricular septal defect 9.6
907 heart septal defect 9.6
908 neuroendocrine tumor 9.6
909 mitral valve stenosis 9.6
910 thyroid gland cancer 9.6
911 giant cell tumor 9.6
912 neuroma 9.6
913 encephalomalacia 9.6
914 post-traumatic stress disorder 9.6
915 hereditary multiple exostoses 9.6
916 essential thrombocythemia 9.6
917 myeloproliferative neoplasm 9.6
918 thrombocytosis 9.6
919 hepatitis 9.6
920 gastroenteritis 9.6
921 generalized atherosclerosis 9.6
922 hyperpituitarism 9.6
923 basal cell carcinoma 9.6
924 orchitis 9.6
925 testicular disease 9.6
926 agammaglobulinemia 9.6
927 kidney cancer 9.6
928 myoma 9.6
929 bilirubin metabolic disorder 9.6
930 auditory system disease 9.6
931 glycogen storage disease 9.6
932 nonspecific interstitial pneumonia 9.6
933 bruxism 9.6
934 severe acute respiratory syndrome 9.6
935 pulmonary tuberculosis 9.6
936 bursitis 9.6
937 cystic kidney disease 9.6
938 papillary carcinoma 9.6
939 cutis laxa 9.6
940 skin squamous cell carcinoma 9.6
941 tropical spastic paraparesis 9.6
942 lysosomal storage disease 9.6
943 demyelinating disease 9.6
944 myelitis 9.6
945 causalgia 9.6
946 lipid pneumonia 9.6
947 syringomyelia 9.6
948 central nervous system disease 9.6
949 bacterial vaginosis 9.6
950 palmoplantar keratosis 9.6
951 breast disease 9.6
952 plague 9.6
953 necrobiosis lipoidica 9.6
954 chronic wasting disease 9.6
955 superior mesenteric artery syndrome 9.6
956 olfactory neuroblastoma 9.6
957 leukorrhea 9.6
958 vaginal discharge 9.6
959 lung squamous cell carcinoma 9.6
960 thyroid gland papillary carcinoma 9.6
961 dentinogenesis imperfecta 9.6
962 intracranial thrombosis 9.6
963 hypertrichosis 9.6
964 carcinosarcoma 9.6
965 polyradiculoneuropathy 9.6
966 seminoma 9.6
967 macular retinal edema 9.6
968 bartter disease 9.6
969 pseudohypoaldosteronism 9.6
970 persian gulf syndrome 9.6
971 hypotrichosis 9.6
972 familial retinoblastoma 9.6
973 uremia 9.6
974 calciphylaxis 9.6
975 aggressive systemic mastocytosis 9.6
976 movement disease 9.6
977 eunuchism 9.6
978 ovarian cyst 9.6
979 chronic inflammatory demyelinating polyradiculoneuropathy 9.6
980 eye disease 9.6
981 adenosine deaminase deficiency 9.6
982 hemolytic anemia 9.6
983 brown-sequard syndrome 9.6
984 acute stress disorder 9.6
985 epithelioid sarcoma 9.6
986 conjunctivitis 9.6
987 reactive arthritis 9.6
988 renal oncocytoma 9.6
989 combined t cell and b cell immunodeficiency 9.6
990 inherited metabolic disorder 9.6
991 kummell's disease 9.6
992 myositis ossificans 9.6
993 compartment syndrome 9.6
994 mitochondrial metabolism disease 9.6
995 premenstrual tension 9.6
996 active peptic ulcer disease 9.6
997 neuroblastoma 9.6
998 childhood leukemia 9.6
999 complement component 3 deficiency 9.6
1000 retinal degeneration 9.6
1001 localized scleroderma 9.6
1002 dermatitis herpetiformis 9.6
1003 nervous system disease 9.6
1004 smallpox 9.6
1005 fascioliasis 9.6
1006 viral infectious disease 9.6
1007 exophthalmos 9.6
1008 iridocyclitis 9.6
1009 acute myocardial infarction 9.6
1010 diabetes insipidus 9.6
1011 fasciitis 9.6
1012 necrotizing fasciitis 9.6
1013 pathologic nystagmus 9.6
1014 tenosynovitis 9.6
1015 peripheral vertigo 9.6
1016 alopecia areata 9.6
1017 hypereosinophilic syndrome 9.6
1018 microcephaly 9.6
1019 myotonic dystrophy 9.6
1020 cleidocranial dysplasia spectrum disorder 9.6
1021 hypermobile ehlers-danlos syndrome 9.6
1022 isolated gonadotropin-releasing hormone deficiency 9.6
1023 juvenile hereditary hemochromatosis 9.6
1024 kat6b-related disorders 9.6
1025 mitochondrial disorders 9.6
1026 multiple epiphyseal dysplasia, recessive 9.6
1027 spondylocostal dysostosis, autosomal recessive 9.6
1028 allergic encephalomyelitis 9.6
1029 central congenital hypothyroidism 9.6
1030 chiari malformation 9.6
1031 chromosomal triplication 9.6
1032 chromosome 20p duplication 9.6
1033 dentinogenesis imperfecta type 2 9.6
1034 dwarfism 9.6
1035 epilepsy progressive myoclonic type 3 9.6
1036 germ cells tumors 9.6
1037 glossodynia 9.6
1038 heparin-induced thrombocytopenia 9.6
1039 homologous wasting disease 9.6
1040 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
1041 hyperadrenalism 9.6
1042 idiopathic neutropenia 9.6
1043 lathyrism 9.6
1044 lymphangiectasis 9.6
1045 medullary sponge kidney 9.6
1046 ovarian epithelial cancer 9.6
1047 precocious puberty 9.6
1048 primary intestinal lymphangiectasia 9.6
1049 pure autonomic failure 9.6
1050 pustular psoriasis 9.6
1051 slc4a1-associated distal renal tubular acidosis 9.6
1052 spastic paraparesis 9.6
1053 sudden sensorineural hearing loss 9.6
1054 synovial chondromatosis 9.6
1055 thrombasthenia 9.6
1056 transverse myelitis 9.6
1057 raynaud phenomenon 9.6
1058 bunion 9.6
1059 combined pituitary hormone deficiency 9.6
1060 cytomegalovirus infection 9.6
1061 dysautonomia 9.6
1062 headache 9.6
1063 posttransplant acute limbic encephalitis 9.6
1064 congenital hypogonadotropic hypogonadism 9.6
1065 cerebrofacial arteriovenous metameric syndrome 9.6
1066 familial calcium pyrophosphate deposition 9.6
1067 isolated bone marrow mastocytosis 9.6
1068 autosomal dominant epidermolytic ichthyosis 9.6
1069 autosomal recessive malignant osteopetrosis 9.6
1070 bone sarcoma 9.6
1071 amelia 9.6
1072 eosinophilic colitis 9.6
1073 traumatic avascular necrosis 9.6
1074 idiopathic avascular necrosis 9.6
1075 erythema multiforme major 9.6
1076 autoimmune hypoparathyroidism 9.6
1077 acute liver failure 9.6
1078 moderate and severe traumatic brain injury 9.6
1079 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1080 acute adrenal insufficiency 9.6

Graphical network of the top 20 diseases related to Bone Mineral Density Quantitative Trait Locus 15:



Diseases related to Bone Mineral Density Quantitative Trait Locus 15

Symptoms & Phenotypes for Bone Mineral Density Quantitative Trait Locus 15

Human phenotypes related to Bone Mineral Density Quantitative Trait Locus 15:

31 (showing 1, show less)
# Description HPO Frequency HPO Source Accession
1 osteoporosis 31 HP:0000939

Symptoms via clinical synopsis from OMIM:

56
Skeletal:
osteoporosis
compression fractures (in homozygotes)
metaphyseal fractures (in homozygotes)

Clinical features from OMIM:

613418

UMLS symptoms related to Bone Mineral Density Quantitative Trait Locus 15:


tremor, angina pectoris, back pain, sciatica, equilibration disorder, muscle cramp, pelvic pain

Drugs & Therapeutics for Bone Mineral Density Quantitative Trait Locus 15

Drugs for Bone Mineral Density Quantitative Trait Locus 15 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 642, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Linagliptin Approved Phase 4 668270-12-0 10096344
2
Dinoprostone Approved Phase 4 363-24-6 5280360
3
Acetaminophen Approved Phase 4 103-90-2 1983
4
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
5
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
6
Teriparatide Approved, Investigational Phase 4 52232-67-4 16133850
7
Risedronate Approved, Investigational Phase 4 105462-24-6 5245
8
Esomeprazole Approved, Investigational Phase 4 161973-10-0, 161796-78-7, 119141-88-7 4594 9568614
9
Tibolone Approved, Investigational Phase 4 5630-53-5
10
Atorvastatin Approved Phase 4 134523-00-5 60823
11
Etanercept Approved, Investigational Phase 4 185243-69-0
12
Pamidronate Approved Phase 4 40391-99-9 4674
13
Montelukast Approved Phase 4 158966-92-8 5281040
14
Adalimumab Approved Phase 4 331731-18-1 16219006
15
Norethindrone Approved Phase 4 68-22-4 6230
16
Potassium citrate Approved, Investigational, Vet_approved Phase 4
17
Cinacalcet Approved Phase 4 226256-56-0 156419
18
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
19
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
20
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
21
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 11128-99-7, 4474-91-3 172198
22
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
23
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
24
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
25
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
26
Gliclazide Approved Phase 4 21187-98-4 3475
27
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
28
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
29
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
30
Ribavirin Approved Phase 4 36791-04-5 37542
31
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
32
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
33
Liraglutide Approved Phase 4 204656-20-2 44147092
34
Azathioprine Approved Phase 4 446-86-6 2265
35
Darunavir Approved Phase 4 206361-99-1, 635728-49-3 213039
36
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
37
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
38
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
39
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
40
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
41
Salmon Calcitonin Approved, Investigational Phase 4 47931-85-1 16129616
42
Sodium citrate Approved, Investigational Phase 4 68-04-2
43
Anastrozole Approved, Investigational Phase 4 120511-73-1 2187